Impact of fluorescein on the antimicrobial efficacy of photoactivated riboflavin in corneal collagen cross-linking

Journal of Refractive Surgery

Volumn 29, Issue 12, 2013, Pages 842-845

  Richoz, Olivier ^a   Gatzioufas, Zisis ^a   Francois, Patrice ^a   Schrenzel, Jacques ^a   Hafezi, Farhad ^a,b  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE DERIVATIVE; COLLAGEN; FLUORESCEIN; MACROLIDE; QUINOLONE DERIVATIVE; RIBOFLAVIN;

ABSORPTION SPECTROSCOPY; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL CELL; CELL DENSITY; CORNEA; CORNEA COLLAGEN CROSS LINKING; IN VITRO STUDY; IRRADIATION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PHOTOACTIVATION; PRIORITY JOURNAL; PROTEIN CROSS LINKING; RADIATION ABSORPTION; SPECTROPHOTOMETER; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET A RADIATION; VISUAL SYSTEM PARAMETERS;

COLLAGEN; COLONY COUNT, MICROBIAL; CORNEAL STROMA; CROSS-LINKING REAGENTS; DRUG INTERACTIONS; FLUORESCEIN; FLUORESCENT DYES; MICROBIAL SENSITIVITY TESTS; PHOTOSENSITIZING AGENTS; RIBOFLAVIN; STAPHYLOCOCCUS AUREUS; ULTRAVIOLET RAYS;

EID: 84890903369     PISSN: 1081597X     EISSN: 19382391     Source Type: Journal    
DOI: 10.3928/1081597X-20131115-01     Document Type: Article

References (27)

1. Jones DB. Decision-making in the management of microbial keratitis. Ophthalmology. 1981;88:814-820.
2. Sharma N, Sachdev R, Jhanji V, Titiyal JS, Vajpayee RB. Therapeutic keratoplasty for microbial keratitis. Curr Opin Ophthalmol. 2010;21:293-300.
3. Hafezi F, Kanellopoulos J, Wiltfang R, Seiler T. Corneal collagen crosslinking with riboflavin and ultraviolet A to treat induced keratectasia after laser in situ keratomileusis. J Cataract Refract Surg. 2007;33:2035-2040.
4. Richoz O, Mavrakanas N, Pajic B, Hafezi F. Corneal collagen cross-linking for ectasia after LASIK and PRK: long-term results. Ophthalmology. 2013;120:1354-1359.
5. Wollensak G, Spoerl E, Seiler T. Riboflavin/ultraviolet-a-induced collagen crosslinking for the treatment of keratoconus. Am J Ophthalmol. 2003;135:620-627.
6. Martins SA, Combs JC, Noguera G, et al. Antimicrobial efficacy of riboflavin/UVA combination (365 nm) in vitro for bacterial and fungal isolates: a potential new treatment for infectious keratitis. Invest Ophthalmol Vis Sci. 2008;49:3402-3408.
7. Galperin G, Berra M, Tau J, Boscaro G, Zarate J, Berra A. Treatment of fungal keratitis from Fusarium infection by corneal cross-linking. Cornea. 2012;31:176-180.
8. Iseli HP, Thiel MA, Hafezi F, Kampmeier J, Seiler T. Ultraviolet A/riboflavin corneal cross-linking for infectious keratitis associated with corneal melts. Cornea. 2008;27:590-594.
9. Kashiwabuchi RT, Carvalho FR, Khan YA, Hirai F, Campos MS, McDonnell PJ. Assessment of fungal viability after long-wave ultraviolet light irradiation combined with riboflavin administration. Graefes Arch Clin Exp Ophthalmol. 2013;251:521-527.
10. Makdoumi K, Mortensen J, Crafoord S. Infectious keratitis treated with corneal crosslinking. Cornea. 2010;29:1353-1358.
11. Makdoumi K, Mortensen J, Sorkhabi O, Malmvall BE, Crafoord S. UVA-riboflavin photochemical therapy of bacterial keratitis: a pilot study. Graefes Arch Clin Exp Ophthalmol. 2012;250:95-102.
12. Panda A, Krishna SN, Kumar S. Photo-activated riboflavin therapy of refractory corneal ulcers. Cornea. 2012;31:1210-1213.
13. Shah A, Sachdev A, Coggon D, Hossain P. Geographic variations in microbial keratitis: an analysis of the peer-reviewed literature. Br J Ophthalmol. 2011;95:762-767.
14. DeMuri GP, Hostetter MK. Resistance to antifungal agents. Pediatr Clin North Am. 1995;42:665-685.
15. Hong J, Chen J, Sun X, et al. Paediatric bacterial keratitis cases in Shanghai: microbiological profile, antibiotic susceptibility and visual outcomes. Eye (Lond). 2012;26:1571-1578.
16. Levy SB. Multidrug resistance: a sign of the times. N Engl J Med. 1998;338:1376-1378.
17. Lichtinger A, Yeung SN, Kim P, et al. Shifting trends in bacterial keratitis in Toronto: an 11-year review. Ophthalmology. 2012;119:1785-1790.
18. Neu HC. The crisis in antibiotic resistance. Science. 1992;257:1064-1073.
19. Sauer A, Letscher-Bru V, Speeg-Schatz C, et al. In vitro efficacy of antifungal treatment using riboflavin/UV-A (365 nm) combination and amphotericin B. Invest Ophthalmol Vis Sci. 2010;51:3950-3953.
20. Schairer DO, Chouake JS, Nosanchuk JD, Friedman AJ. The potential of nitric oxide releasing therapies as antimicrobial agents. Virulence. 2012;3:271-279.
21. Spoerl E, Wollensak G, Seiler T. Increased resistance of cross-linked cornea against enzymatic digestion. Curr Eye Res. 2004;29:35-40.
22. Salomao MQ, Chaurasia SS, Sinha-Roy A, et al. Corneal wound healing after ultraviolet-A/riboflavin collagen cross-linking: a rabbit study. J Refract Surg. 2011;27:401-407.
23. Kozobolis V, Labiris G, Gkika M, et al. UV-A collagen cross-linking treatment of bullous keratopathy combined with corneal ulcer. Cornea. 2010;29:235-238.
24. Muller L, Thiel MA, Kipfer-Kauer AI, Kaufmann C. Corneal cross-linking as supplementary treatment option in melting keratitis: a case series. Klin Monbl Augenheilkd. 2012;229:411-415.
25. Spiess BM, Pot SA, Florin M, Hafezi F. Corneal collagen cross-linking (CXL) for the treatment of melting keratitis in cats and dogs: a pilot study [published online ahead of print January 29, 2013]. Vet Ophthalmol. doi:10.1111/vop.12027
26. Morgan PB, Maldonado-Codina C. Corneal staining: do we really understand what we are seeing? Cont Lens Anterior Eye. 2009;32:48-54.
27. PubChem. Riboflavin-compound summary. National Institute of Health, National Library of Medicine web site: http://pub-chem.ncbi.nlm.nih.gov/summary/ summary.cgi?cid=493570. Accessed on July 16, 2013.